Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells

Details for Australian Patent Application No. 2004296184 (hide)

Owner Vaccinex, Inc.

Inventors Smith, Ernest S.; Paris, Mark J.; Evans, Elizabeth E.; Zauderer, Maurice; Sahasrabudhe, Deepak M.

Agent Callinan

Pub. Number AU-B-2004296184

PCT Pub. Number WO2005/055936

Priority 60/531,688 23.12.03 US; 60/526,572 04.12.03 US

Filing date 6 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 16 December 2010

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/055936 Priority application(s): WO2005/055936

16 December 2010 Application Accepted

  Published as AU-B-2004296184

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296186-Systems and methods related to degradation of uremic toxins

2004296183-Methods for treating prostate cancer with herbal compositions